BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008;12:2189-204. [PMID: 19120703 DOI: 10.1111/j.1582-4934.2008.00533.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 180] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Giovannini C, Fornari F, Piscaglia F, Gramantieri L. Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. Cells 2021;10:521. [PMID: 33804511 DOI: 10.3390/cells10030521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Matsuda Y, Wakai T, Kubota M, Takamura M, Yamagiwa S, Aoyagi Y, Osawa M, Fujimaki S, Sanpei A, Genda T. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma. Med Mol Morphol. 2013;46:185-192. [PMID: 23640750 DOI: 10.1007/s00795-013-0047-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
3 Kim J, Jiang J, Badawi M, Schmittgen TD. miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway. Biochem Biophys Res Commun 2017;487:709-15. [PMID: 28442344 DOI: 10.1016/j.bbrc.2017.04.121] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
4 Qin A, Zhu J, Liu X, Zeng D, Gu M, Lv C. MicroRNA-1271 inhibits cellular proliferation of hepatocellular carcinoma. Oncol Lett 2017;14:6783-8. [PMID: 29181102 DOI: 10.3892/ol.2017.7052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
5 Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem. 2011;286:36677-36685. [PMID: 21878637 DOI: 10.1074/jbc.m111.270561] [Cited by in Crossref: 165] [Cited by in F6Publishing: 111] [Article Influence: 15.0] [Reference Citation Analysis]
6 Sakr M, Takino T, Sabit H, Nakada M, Li Z, Sato H. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase. Gene 2016;587:155-62. [DOI: 10.1016/j.gene.2016.04.058] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
7 Zheng B, Zhu YJ, Wang HY, Chen L. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci. 2017;60:575-584. [PMID: 28547581 DOI: 10.1007/s11427-016-9043-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
8 Yin H, Peng X, Ren P, Cheng B, Li S, Qin C. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis. Tumour Biol 2014;35:12317-26. [PMID: 25204672 DOI: 10.1007/s13277-014-2544-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
9 Hesketh RL, Zhu AX, Oklu R. Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma? Diagn Interv Radiol 2015;21:78-84. [PMID: 25430530 DOI: 10.5152/dir.2014.14237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
10 Bae JS, Kim J, Pasaje CFA, Cheong HS, Lee TH, Koh IS, Lee H, Kim YJ, Shin HD. Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases. Digestive and Liver Disease 2012;44:849-54. [DOI: 10.1016/j.dld.2012.04.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
11 Chen Z, Liu Y, Yang L, Liu P, Zhang Y, Wang X. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. Immunol Lett 2020;222:40-8. [PMID: 32194141 DOI: 10.1016/j.imlet.2020.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
12 Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15(45): 5633-5640 [PMID: 19960558 DOI: 10.3748/wjg.15.5633] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 107] [Article Influence: 8.0] [Reference Citation Analysis]
13 Bishayee A. The role of inflammation and liver cancer. Adv Exp Med Biol. 2014;816:401-435. [PMID: 24818732 DOI: 10.1007/978-3-0348-0837-8_16] [Cited by in Crossref: 130] [Cited by in F6Publishing: 123] [Article Influence: 16.3] [Reference Citation Analysis]
14 Shih T, Tien Y, Wen C, Yeh T, Yu M, Huang C, Lee Y, Yen T, Hsieh S. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. Journal of Hepatology 2012;57:584-91. [DOI: 10.1016/j.jhep.2012.04.031] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 13.7] [Reference Citation Analysis]
15 Das SK, Sokhi UK, Bhutia SK, Azab B, Su ZZ, Sarkar D, Fisher PB. Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells. Proc Natl Acad Sci U S A 2010;107:11948-53. [PMID: 20547861 DOI: 10.1073/pnas.0914143107] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
16 Lu G, Ma Y, Jia C, Yang H, Xie R, Luo P, Chai L, Cai H, Cai M, Lv Z, Cong X, Fu D. Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer. Oncol Lett 2017;14:5952-8. [PMID: 29113231 DOI: 10.3892/ol.2017.6902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Qi J, Wang J, Katayama H, Sen S, Liu SM. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. neo 2012;60:135-42. [DOI: 10.4149/neo_2013_018] [Cited by in Crossref: 75] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
18 Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009;285:116-26. [PMID: 19464788 DOI: 10.1016/j.canlet.2009.04.031] [Cited by in Crossref: 289] [Cited by in F6Publishing: 280] [Article Influence: 22.2] [Reference Citation Analysis]
19 Shen J, Wang S, Siegel AB, Remotti H, Wang Q, Sirosh I, Santella RM. Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis. Gastroenterol Res Pract 2015;2015:230642. [PMID: 25861255 DOI: 10.1155/2015/230642] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
20 Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 2011;19:232-243. [PMID: 21316602 DOI: 10.1016/j.ccr.2011.01.001] [Cited by in Crossref: 492] [Cited by in F6Publishing: 489] [Article Influence: 44.7] [Reference Citation Analysis]
21 Aravalli RN. Development of microRNA therapeutics for hepatocellular carcinoma. Diagnostics. 2013;3:170-191. [PMID: 26835673 DOI: 10.3390/diagnostics3010170] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
22 Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010;103:1215-20. [PMID: 20842113 DOI: 10.1038/sj.bjc.6605895] [Cited by in Crossref: 185] [Cited by in F6Publishing: 175] [Article Influence: 15.4] [Reference Citation Analysis]
23 Rong M, Chen G, Dang Y. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer. 2013;13:21. [PMID: 23320393 DOI: 10.1186/1471-2407-13-21] [Cited by in Crossref: 77] [Cited by in F6Publishing: 88] [Article Influence: 8.6] [Reference Citation Analysis]
24 He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2012;31:3357-3369. [PMID: 22056881 DOI: 10.1038/onc.2011.500] [Cited by in Crossref: 231] [Cited by in F6Publishing: 235] [Article Influence: 21.0] [Reference Citation Analysis]
25 Farber BA, Lalazar G, Simon EP, Hammond WJ, Requena D, Bhanot UK, La Quaglia MP, Simon SM. Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. Oncotarget 2018;9:10211-27. [PMID: 29535801 DOI: 10.18632/oncotarget.23325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
26 Sartorius K, An P, Winkler C, Chuturgoon A, Li X, Makarova J, Kramvis A. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Front Immunol 2021;12:661204. [PMID: 33995383 DOI: 10.3389/fimmu.2021.661204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sun J, Wei X, Xu L. Upregulation of lncRNA Sox2ot indicates a poor prognosis for patients with hepatocellular carcinoma and promotes cell invasion. Oncol Lett 2018;16:1189-95. [PMID: 29963193 DOI: 10.3892/ol.2018.8725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
28 Callegari E, Gramantieri L, Domenicali M, D’Abundo L, Sabbioni S, Negrini M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22:46-57. [PMID: 25190143 DOI: 10.1038/cdd.2014.136] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 10.6] [Reference Citation Analysis]
29 Martin M, Herceg Z. From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med. 2012;4:8. [PMID: 22293089 DOI: 10.1186/gm307] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
30 Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ. Development of the human cancer microRNA network. Silence. 2010;1:6. [PMID: 20226080 DOI: 10.1186/1758-907X-1-6] [Cited by in Crossref: 169] [Cited by in F6Publishing: 93] [Article Influence: 14.1] [Reference Citation Analysis]
31 Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. MicroRNA-21 gene and cancer. Med Oncol. 2013;30:376. [PMID: 23277281 DOI: 10.1007/s12032-012-0376-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
32 Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Oncogene. 2012;31:3607-3620. [PMID: 22105365 DOI: 10.1038/onc.2011.523] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 7.4] [Reference Citation Analysis]
33 Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A, Kramvis A. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020;12:E746. [PMID: 32664401 DOI: 10.3390/v12070746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
34 Manservigi R, Argnani R, Marconi P. HSV Recombinant Vectors for Gene Therapy. Open Virol J 2010;4:123-56. [PMID: 20835362 DOI: 10.2174/1874357901004030123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Sun J, Bie B, Zhang S, Yang J, Li Z. Long non-coding RNAs: critical players in hepatocellular carcinoma. Int J Mol Sci. 2014;15:20434-20448. [PMID: 25387074 DOI: 10.3390/ijms151120434] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
36 Sun J, Pi F, Ji J, Lei H, Gao Z, Zhang Y, Habimana JDD, Li Z, Sun X. Ultrasensitive “FRET-SEF” Probe for Sensing and Imaging MicroRNAs in Living Cells Based on Gold Nanoconjugates. Anal Chem 2018;90:3099-108. [DOI: 10.1021/acs.analchem.7b04051] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
37 Wu XG, Zhou CF, Zhang YM, Yan RM, Wei WF, Chen XJ, Yi HY, Liang LJ, Fan LS, Liang L, Wu S, Wang W. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma. Angiogenesis 2019;22:397-410. [PMID: 30993566 DOI: 10.1007/s10456-019-09665-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 16.0] [Reference Citation Analysis]
38 Lee C, Yen C, Liu T. Prediction of personalized microRNA activity. Gene 2013;518:101-6. [DOI: 10.1016/j.gene.2012.11.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Zhang H, Liu H, Bi H. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1. Oncol Rep 2017;38:843-9. [PMID: 28677785 DOI: 10.3892/or.2017.5772] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
40 Jang JY, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma. Exp Mol Med. 2013;45:e3. [PMID: 23306701 DOI: 10.1038/emm.2013.1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
41 Tessitore A, Cicciarelli G, Del Vecchio F, Gaggiano A, Verzella D, Fischietti M, Mastroiaco V, Vetuschi A, Sferra R, Barnabei R, Capece D, Zazzeroni F, Alesse E. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice. BMC Cancer 2016;16:3. [PMID: 26728044 DOI: 10.1186/s12885-015-2007-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
42 Hu S, Tao R, Wang S, Wang C, Zhao X, Zhao H, Li L, Zhu S, He Y, Jiang X, Gao Y. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1. Tumor Biol 2015;36:5467-72. [DOI: 10.1007/s13277-015-3213-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
43 Jiang P, Wang J, Zhu S, Hu C, Lin Y, Pan W. Identification of a Schistosoma japonicum MicroRNA That Suppresses Hepatoma Cell Growth and Migration by Targeting Host FZD4 Gene. Front Cell Infect Microbiol 2022;12:786543. [DOI: 10.3389/fcimb.2022.786543] [Reference Citation Analysis]
44 Gramantieri L, Giovannini C, Piscaglia F, Fornari F. MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:369-85. [PMID: 34012928 DOI: 10.2147/JHC.S268292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Zhang Y, Kang R, Liu W, Yang Y, Ding R, Huang Q, Meng J, Xiong L, Guo Z. Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma. Int J Biol Sci 2017;13:1213-21. [PMID: 29104512 DOI: 10.7150/ijbs.21502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
46 Anestopoulos I, Voulgaridou GP, Georgakilas AG, Franco R, Pappa A, Panayiotidis MI. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacol Ther. 2015;145:103-119. [PMID: 25205159 DOI: 10.1016/j.pharmthera.2014.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
47 Duan CL, Hou GH, Liu YP, Liang T, Song J, Han JK, Zhang C. Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma. Tumour Biol 2014;35:12205-15. [PMID: 25164610 DOI: 10.1007/s13277-014-2529-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Pogribny IP, James SJ, Beland FA. Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. Mol Nutr Food Res 2012;56:116-25. [DOI: 10.1002/mnfr.201100524] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
49 Yu G, Mu H, Zhou H, Fang F, Cui Y, Wu Q, Xiong Q, Li H. MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65. Cells Dev 2021;167:203711. [PMID: 34216805 DOI: 10.1016/j.cdev.2021.203711] [Reference Citation Analysis]
50 Song J, Ouyang Y, Che J, Li X, Zhao Y, Yang K, Zhao X, Chen Y, Fan C, Yuan W. Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases. Front Immunol 2017;8:56. [PMID: 28261196 DOI: 10.3389/fimmu.2017.00056] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 11.4] [Reference Citation Analysis]
51 Elemeery MN. Micro-RNA in Hepatocellular Carcinoma - Related Hepatitis C Virus Patients in Correlation to Disease Progression. In: Shahid I, editor. Hepatitis C - From Infection to Cure. InTech; 2018. [DOI: 10.5772/intechopen.76209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Kim WH, Min KT, Jeon YJ, Kwon C, Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, Kim NK. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 2012;504:92-7. [DOI: 10.1016/j.gene.2012.05.014] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 7.6] [Reference Citation Analysis]
53 Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res. 2011;727:55-61. [PMID: 21514401 DOI: 10.1016/j.mrrev.2011.04.001] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 11.0] [Reference Citation Analysis]
54 Xu G, Zhang Y, Wei J, Jia W, Ge Z, Zhang Z, Liu X. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. BMC Cancer. 2013;13:469. [PMID: 24112539 DOI: 10.1186/1471-2407-13-469] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
55 Wang M, Yu F, Li P. Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma. Cancers (Basel) 2018;10:E258. [PMID: 30072625 DOI: 10.3390/cancers10080258] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 13.5] [Reference Citation Analysis]
56 Tunissiolli NM, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino EC, da Silva RF, da Silva RC, Goloni-Bertollo EM. Hepatocellular Carcinoma: a Comprehensive Review of Biomarkers, Clinical Aspects, and Therapy. Asian Pac J Cancer Prev. 2017;18:863-872. [PMID: 28545181 DOI: 10.22034/apjcp.2017.18.4.863] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
57 Jeyaram C, Philip M, Perumal RC, Benny J, Jayakumari JM, Ramasamy MS. A Computational Approach to Identify Novel Potential Precursor miRNAs and their Targets from Hepatocellular Carcinoma Cells. CBIO 2018;14:24-32. [DOI: 10.2174/1574893613666180413150351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T. MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1. Onco Targets Ther 2015;8:2227-35. [PMID: 26347321 DOI: 10.2147/OTT.S87976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
59 Shen G, Lin Y, Yang X, Zhang J, Xu Z, Jia H. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X. BMC Cancer. 2014;14:393. [PMID: 24890815 DOI: 10.1186/1471-2407-14-393] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
60 Finch ML, Marquardt JU, Yeoh GC, Callus BA. Regulation of microRNAs and their role in liver development, regeneration and disease. Int J Biochem Cell Biol. 2014; Apr 13. [Epub ahead of print]. [PMID: 24731940 DOI: 10.1016/j.biocel.2014.04.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
61 Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR, Banerjee S, Schmittgen TD. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2010;403:120-125. [PMID: 21055388 DOI: 10.1016/j.bbrc.2010.10.130] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 8.0] [Reference Citation Analysis]
62 Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, Bi J, Zhang LJ, Su Q, Zeng WT. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol. 2011;225:463-472. [PMID: 21671467 DOI: 10.1002/path.2877] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 8.0] [Reference Citation Analysis]
63 Karolina D, Jeyaseelan K. micro RNAs as Therapeutic Agents and Targets. In: Cheng K, Mahato RI, editors. Advanced Delivery and Therapeutic Applications of RNAi. Chichester: John Wiley and Sons, Ltd; 2013. pp. 439-82. [DOI: 10.1002/9781118610749.ch19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Chen X, Zhu X, Wei Z, Lv Q. Identification and Differential Expression of microRNA in Response to Elevated Phospholipase Cγ Expression in Liver RH 35 Carcinoma Cells. Cytol Genet 2020;54:555-65. [DOI: 10.3103/s009545272006002x] [Reference Citation Analysis]
65 Gyöngyösi B, Végh É, Járay B, Székely E, Fassan M, Bodoky G, Schaff Z, Kiss A. Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma. J Histochem Cytochem 2014;62:547-55. [PMID: 24804874 DOI: 10.1369/0022155414537277] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
66 Yuan JH, Yang F, Chen BF, Lu Z, Huo XS, Zhou WP, Wang F, Sun SH. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Hepatology. 2011;54:2025-2035. [PMID: 21837748 DOI: 10.1002/hep.24606] [Cited by in Crossref: 118] [Cited by in F6Publishing: 115] [Article Influence: 11.8] [Reference Citation Analysis]
67 Chang S, Chen B, Wang X, Wu K, Sun Y. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. BMC Cancer 2017;17:248. [PMID: 28388883 DOI: 10.1186/s12885-017-3216-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 15.8] [Reference Citation Analysis]
68 Halász T, Horváth G, Pár G, Werling K, Kiss A, Schaff Z, Lendvai G. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. World J Gastroenterol 2015; 21(25): 7814-7823 [PMID: 26167081 DOI: 10.3748/wjg.v21.i25.7814] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
69 Lan FF, Wang H, Chen YC, Chan CY, Ng SS, Li K, Xie D, He ML, Lin MC, Kung HF. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer. 2011;128:319-331. [PMID: 20309945 DOI: 10.1002/ijc.25336] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 9.3] [Reference Citation Analysis]
70 Pollutri D, Patrizi C, Marinelli S, Giovannini C, Trombetta E, Giannone FA, Baldassarre M, Quarta S, Vandewynckel YP, Vandierendonck A, Van Vlierberghe H, Porretti L, Negrini M, Bolondi L, Gramantieri L, Fornari F. The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma. Cell Death Dis 2018;9:4. [PMID: 29305580 DOI: 10.1038/s41419-017-0076-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
71 Xie K, Liu J, Zhu L, Liu Y, Pan Y, Wen J, Ma H, Zhai X, Hu Z. A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma. Cancer Epidemiol. 2013;37:998-1002. [PMID: 24103425 DOI: 10.1016/j.canep.2013.09.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
72 He Q, Huang Y, Cai L, Zhang S, Zhang C. Expression and prognostic value of Ars2 in hepatocellular carcinoma. Int J Clin Oncol 2014;19:880-8. [DOI: 10.1007/s10147-013-0642-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
73 Gupta P, Cairns MJ, Saksena NK. Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma. Virol J. 2014;11:64. [PMID: 24690114 DOI: 10.1186/1743-422x-11-64] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
74 Salim A, Amjesh R, Chandra SS. An approach to forecast human cancer by profiling microRNA expressions from NGS data. BMC Cancer 2017;17:77. [PMID: 28122525 DOI: 10.1186/s12885-016-3042-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
75 Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M. Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med 2015;7:1-10. [PMID: 25926760 DOI: 10.2147/HMER.S50161] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
76 Kan T, Meltzer SJ. MicroRNAs in Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol. 2009;9:727-732. [PMID: 19773200 DOI: 10.1016/j.coph.2009.08.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
77 Romilda C, Marika P, Alessandro S, Enrico L, Marina B, Andromachi K, Umberto C, Giacomo Z, Claudia M, Massimo R. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer. 2012;12:177. [PMID: 22587342 DOI: 10.1186/1471-2407-12-177] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
78 van Malenstein H, van Pelt J, Verslype C. Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer. 2011;47:1789-1797. [PMID: 21612914 DOI: 10.1016/j.ejca.2011.04.027] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
79 Wang H, Gao B. MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops. Hepatology 2014;60:1466-8. [PMID: 24996014 DOI: 10.1002/hep.27287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol. 2009;15:5633-5640. [PMID: 19960558 DOI: 10.3748/wjg.15.5633.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Zhang L, Zhang T, Deng Z, Sun L. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1. Oncol Rep 2019;41:1669-77. [PMID: 30664185 DOI: 10.3892/or.2019.6971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
82 Tang J, Li L, Huang W, Sui C, Yang Y, Lin X, Hou G, Chen X, Fu J, Yuan S. MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. Cancer Lett. 2015;364:33-43. [PMID: 25931210 DOI: 10.1016/j.canlet.2015.04.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
83 Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int 2012;32:752-60. [DOI: 10.1111/j.1478-3231.2011.02750.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 144] [Article Influence: 15.1] [Reference Citation Analysis]
84 Marrone AK, Shpyleva S, Chappell G, Tryndyak V, Uehara T, Tsuchiya M, Beland FA, Rusyn I, Pogribny IP. Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice. Mol Carcinog 2016;55:808-17. [PMID: 25865624 DOI: 10.1002/mc.22323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
85 Cardin R, Piciocchi M, Sinigaglia A, Lavezzo E, Bortolami M, Kotsafti A, Cillo U, Zanus G, Mescoli C, Rugge M. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer. 2012;12:177. [PMID: 22587342 DOI: 10.1186/1471-2407-12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Fognani E, Giannini C, Piluso A, Gragnani L, Monti M, Caini P, Ranieri J, Urraro T, Triboli E, Laffi G. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PLoS One. 2013;8:e62965. [PMID: 23650540 DOI: 10.1371/journal.pone.0062965] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
87 Rokavec M, Li H, Jiang L, Hermeking H. The p53/microRNA connection in gastrointestinal cancer. Clin Exp Gastroenterol 2014;7:395-413. [PMID: 25328413 DOI: 10.2147/CEG.S43738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
88 Liu WH, Ren LN, Wang X, Wang T, Zhang N, Gao Y, Luo H, Navarro-Alvarez N, Tang LJ. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats. J Cancer Res Clin Oncol. 2015;141:1767-1778. [PMID: 25724413 DOI: 10.1007/s00432-015-1943-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
89 Katayama Y, Maeda M, Miyaguchi K, Nemoto S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S, Tanaka H. Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett 2012;4:817-23. [PMID: 23205106 DOI: 10.3892/ol.2012.810] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
90 Aravalli RN, Cressman EN, Steer CJ. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol. 2013;87:227-247. [PMID: 23007558 DOI: 10.1007/s00204-012-0931-2] [Cited by in Crossref: 136] [Cited by in F6Publishing: 137] [Article Influence: 13.6] [Reference Citation Analysis]
91 Baek S, Cho KJ, Ju HL, Moon H, Choi SH, Chung SI, Park JY, Choi KH, Kim DY, Ahn SH, Han KH, Ro SW. Analysis of miRNA expression patterns in human and mouse hepatocellular carcinoma cells. Hepatol Res 2015;45:1331-40. [PMID: 25704452 DOI: 10.1111/hepr.12510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
92 Sun D, Lu J, Hu C, Zhang Q, Wang X, Zhang Z, Hu S. Prognostic role of miR-760 in hepatocellular carcinoma. Oncol Lett. 2018;16:7239-7244. [PMID: 30546462 DOI: 10.3892/ol.2018.9546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
93 Fu Y, Wei X, Tang C, Li J, Liu R, Shen A, Wu Z. Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncol Lett. 2013;6:1811-1815. [PMID: 24260081 DOI: 10.3892/ol.2013.1638] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
94 Thorsen SB, Obad S, Jensen NF, Stenvang J, Kauppinen S. The therapeutic potential of microRNAs in cancer. Cancer J. 2012;18:275-284. [PMID: 22647365 DOI: 10.1097/ppo.0b013e318258b5d6] [Cited by in Crossref: 77] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
95 Montella M, D'Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, Barbieri A, D'Ursi AM, Tecce MF, Amore A, Galdiero M, Ciliberto G, Giudice A. Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Int J Endocrinol 2015;2015:854530. [PMID: 26491442 DOI: 10.1155/2015/854530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
96 Sun H, Cui C, Xiao F, Wang H, Xu J, Shi X, Yang Y, Zhang Q, Zheng X, Yang X, Wu C, Wang L. miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON. Hepatol Res 2015;45:1312-22. [PMID: 25655186 DOI: 10.1111/hepr.12500] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
97 Jin Y, Wang J, Han J, Luo D, Sun Z. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Exp Cell Res 2017;360:210-7. [PMID: 28890291 DOI: 10.1016/j.yexcr.2017.09.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
98 Zhang X, Hu S, Zhang X, Wang L, Zhang X, Yan B, Zhao J, Yang A, Zhang R. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2014;443:1078-1084. [PMID: 24370822 DOI: 10.1016/j.bbrc.2013.12.095] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 8.3] [Reference Citation Analysis]
99 Zhang Y, Zheng SJ, Duan ZP. Functions of microRNA-21 in the liver. Shijie Huaren Xiaohua Zazhi 2010; 18(25): 2621-2625 [DOI: 10.11569/wcjd.v18.i25.2621] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Oh SE, Park HJ, He L, Skibiel C, Junn E, Mouradian MM. The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress. Redox Biol 2018;19:62-73. [PMID: 30107296 DOI: 10.1016/j.redox.2018.07.021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
101 Lim L, Tran BM, Vincan E, Locarnini S, Warner N. HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA. Future Virology 2012;7:1237-49. [DOI: 10.2217/fvl.12.113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Pogribny IP. MicroRNA dysregulation during chemical carcinogenesis. Epigenomics 2009;1:281-90. [PMID: 22122703 DOI: 10.2217/epi.09.17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
103 Li Y, Ding X, Xiu S, Du G, Liu Y. LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells. Onco Targets Ther 2019;12:9887-97. [PMID: 31819486 DOI: 10.2147/OTT.S228917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
104 Qian NS, Liu WH, Lv WP, Xiang X, Su M, Raut V, Chen YL, Dong JH. Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß. PLoS One 2013;8:e68004. [PMID: 23936298 DOI: 10.1371/journal.pone.0068004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
105 Starlard-Davenport A, Tryndyak V, Kosyk O, Ross SR, Rusyn I, Beland FA, Pogribny IP. Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis. J Nutrigenet Nutrigenomics 2010;3:259-66. [PMID: 21474957 DOI: 10.1159/000324362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
106 Cabiati M, Salvadori C, Basta G, Del Turco S, Aretini P, Cecchettini A, Del Ry S. miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles. Clin Exp Med 2021. [PMID: 34319456 DOI: 10.1007/s10238-021-00744-6] [Reference Citation Analysis]
107 Li BA. A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma. Acta Pharmacol Sin 2012;33:3-4. [PMID: 22212428 DOI: 10.1038/aps.2011.198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
108 Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L, Gramantieri L. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol. 2012;227:275-285. [PMID: 22262409 DOI: 10.1002/path.3995] [Cited by in Crossref: 134] [Cited by in F6Publishing: 133] [Article Influence: 13.4] [Reference Citation Analysis]
109 Chang Y, Yan W, He X, Zhang L, Li C, Huang H, Nace G, Geller DA, Lin J, Tsung A. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012; 143: 177-87. e8. [PMID: 22504094 DOI: 10.1053/j.gastro.2012.04.009] [Cited by in Crossref: 184] [Cited by in F6Publishing: 184] [Article Influence: 18.4] [Reference Citation Analysis]
110 Wang R, Zhang J, Jiang W, Ma Y, Li W, Jin B, Hu H, Wang J, Liu Y, Liu J. Association between a variant in microRNA-646 and the susceptibility to hepatocellular carcinoma in a large-scale population. ScientificWorldJournal 2014;2014:312704. [PMID: 25177719 DOI: 10.1155/2014/312704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
111 Hong L, Han Y, Li S, Yang J, Zheng J, Zhang H, Zhao Q, Wu K, Fan D. The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin Biol Ther. 2010;10:1693-1701. [PMID: 20977295 DOI: 10.1517/14712598.2010.532482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
112 Tipanee J, Di Matteo M, Tulalamba W, Samara-Kuko E, Keirsse J, Van Ginderachter JA, Chuah MK, VandenDriessche T. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. Mol Ther Nucleic Acids 2020;19:1309-29. [PMID: 32160703 DOI: 10.1016/j.omtn.2020.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
113 Dokhanchi M, Pakravan K, Zareian S, Hussen BM, Farid M, Razmara E, Mossahebi-Mohammadi M, Cho WC, Babashah S. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3. Life Sci 2021;285:119937. [PMID: 34508764 DOI: 10.1016/j.lfs.2021.119937] [Reference Citation Analysis]
114 Devulapally R, Foygel K, Sekar TV, Willmann JK, Paulmurugan R. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. ACS Appl Mater Interfaces 2016;8:33412-22. [PMID: 27960411 DOI: 10.1021/acsami.6b08153] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
115 Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M. MicroRNA response to environmental mutagens in liver. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011;717:67-76. [DOI: 10.1016/j.mrfmmm.2011.03.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
116 Mathew S, Ali A, Abdel-hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014;26:327-39. [DOI: 10.1016/j.meegid.2014.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
117 Lee J, Choi K, Moon SU, Kim S. Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon. Biomaterials 2016;74:109-18. [DOI: 10.1016/j.biomaterials.2015.09.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
118 Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
119 Zhou J, Cui X, Xiao F, Cai G. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers. Int J Mol Sci 2021;22:1529. [PMID: 33546390 DOI: 10.3390/ijms22041529] [Reference Citation Analysis]
120 Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2014;342:223-230. [PMID: 22306342 DOI: 10.1016/j.canlet.2012.01.038] [Cited by in Crossref: 109] [Cited by in F6Publishing: 114] [Article Influence: 10.9] [Reference Citation Analysis]
121 Au SL, Ng IO, Wong CM. Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins. Front Med 2013;7:231-41. [PMID: 23620257 DOI: 10.1007/s11684-013-0253-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
122 Zhang W, Liu K, Liu S, Ji B, Wang Y, Liu Y. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumor Biol 2015;36:9779-88. [DOI: 10.1007/s13277-015-3749-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
123 Li Z, Wang J, Huang C, Zhang S, Yang J, Jiang A, Zhou R, Pan D. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis. Rapid Commun Mass Spectrom 2010;24:2765-75. [DOI: 10.1002/rcm.4703] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
124 Ma N, Li F, Li D, Hui Y, Wang X, Qiao Y, Zhang Y, Xiang Y, Zhou J, Zhou L, Zheng X, Gao X. Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation. Mol Cell Biochem 2012;361:337-43. [DOI: 10.1007/s11010-011-1121-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
125 Yang H, Cho ME, Li TW, Peng H, Ko KS, Mato JM, Lu SC. MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest 2013;123:285-98. [PMID: 23241961 DOI: 10.1172/JCI63861] [Cited by in Crossref: 89] [Cited by in F6Publishing: 61] [Article Influence: 8.9] [Reference Citation Analysis]
126 Zhang Y, Yang L, Wang S, Liu Z, Xiu M. MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma. CBM 2018;22:151-9. [DOI: 10.3233/cbm-171120] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
127 Mahgoub A, Steer CJ. MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. J Clin Med 2016;5:E52. [PMID: 27171116 DOI: 10.3390/jcm5050052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
128 Dang Z, Xu WH, Lu P, Wu N, Liu J, Ruan B, Zhou L, Song WJ, Dou KF. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Int J Biol Sci 2014;10:733-45. [PMID: 25013381 DOI: 10.7150/ijbs.8097] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
129 Yuan B, Liang Y, Wang D, Luo F. MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients. Cancer Sci 2015;106:819-24. [PMID: 25940592 DOI: 10.1111/cas.12688] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
130 Faltermeier C, Busuttil RW, Zarrinpar A. A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases 2015;3:221-52. [PMID: 28943622 DOI: 10.3390/diseases3040221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Frau M, Biasi F, Feo F, Pascale RM. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. Mol Aspects Med 2010;31:179-93. [PMID: 20176048 DOI: 10.1016/j.mam.2010.02.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]
132 Manservigi R, Argnani R, Marconi P. HSV Recombinant Vectors for Gene Therapy. Open Virol J 2010;4:123-56. [PMID: 20835362 DOI: 10.2174/1874357901004030123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 0.5] [Reference Citation Analysis]
133 Banaudha KK, Verma M. The role of microRNAs in the management of liver cancer. Methods Mol Biol 2012;863:241-51. [PMID: 22359297 DOI: 10.1007/978-1-61779-612-8_14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
134 Huang XC, Pang FX, Ou SS, Wei XJ, Xu YJ, Lai YH. Risk Score Based on Two microRNAs as a Prognostic Marker of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network. Int J Gen Med 2021;14:3377-85. [PMID: 34285562 DOI: 10.2147/IJGM.S318516] [Reference Citation Analysis]
135 Fernández-Tussy P, Rodríguez-Agudo R, Fernández-Ramos D, Barbier-Torres L, Zubiete-Franco I, Davalillo SL, Herraez E, Goikoetxea-Usandizaga N, Lachiondo-Ortega S, Simón J, Lopitz-Otsoa F, Juan VG, McCain MV, Perugorria MJ, Mabe J, Navasa N, Rodrigues CMP, Fabregat I, Boix L, Sapena V, Anguita J, Lu SC, Mato JM, Banales JM, Villa E, Reeves HL, Bruix J, Reig M, Marin JJG, Delgado TC, Martínez-Chantar ML. Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity. Cell Death Dis 2021;12:555. [PMID: 34050139 DOI: 10.1038/s41419-021-03827-0] [Reference Citation Analysis]
136 Bolondi L, Gramantieri L. From liver cirrhosis to HCC. Intern Emerg Med 2011;6 Suppl 1:93-8. [PMID: 22009618 DOI: 10.1007/s11739-011-0682-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
137 Yuan Q, Loya K, Rani B, Möbus S, Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 2013;57:299-310. [PMID: 22821679 DOI: 10.1002/hep.25984] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 10.8] [Reference Citation Analysis]
138 Le XF, Merchant O, Bast RC, Calin GA. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron 2010;3:137-47. [PMID: 21209780 DOI: 10.1007/s12307-010-0037-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 5.9] [Reference Citation Analysis]
139 Shi Z, Luo Y, Zhu M, Zhou Y, Zheng B, Wu D, Wang S, Xie X, Lin H, Yu X. Expression Analysis of Long Non-Coding RNA HAR1A and HAR1B in HBV-Induced Hepatocullular Carcinoma in Chinese Patients. Lab Med 2019;50:150-7. [PMID: 30304523 DOI: 10.1093/labmed/lmy055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
140 Ding W, Tan H, Li X, Zhang Y, Fang F, Tian Y, Li J, Pan X. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma. CBM 2018;22:427-34. [DOI: 10.3233/cbm-171036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
141 Ruan Q, Wang P, Wang T, Qi J, Wei M, Wang S, Fan T, Johnson D, Wan X, Shi W, Sun H, Chen YH. MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2. Cell Death Dis 2014;5:e1095. [PMID: 24577093 DOI: 10.1038/cddis.2014.47] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
142 Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, Feitelson MA. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 2012;7:e35331. [PMID: 22496917 DOI: 10.1371/journal.pone.0035331] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
143 Wang L, Yue Y, Wang X, Jin H. Function and clinical potential of microRNAs in hepatocellular carcinoma. Oncol Lett. 2015;10:3345-3353. [PMID: 26788134 DOI: 10.3892/ol.2015.3759] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
144 Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, Shi W, Chen YH. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011;108:12030-5. [PMID: 21730150 DOI: 10.1073/pnas.1101450108] [Cited by in Crossref: 142] [Cited by in F6Publishing: 134] [Article Influence: 12.9] [Reference Citation Analysis]
145 Benderska N, Dittrich AL, Knaup S, Rau TT, Neufert C, Wach S, Fahlbusch FB, Rauh M, Wirtz RM, Agaimy A. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis. 2015;21:2039-2051. [PMID: 26083618 DOI: 10.1097/mib.0000000000000453] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
146 Lamontagne J, Steel LF, Bouchard MJ. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World J Gastroenterol 2015; 21(24): 7375-7399 [PMID: 26139985 DOI: 10.3748/wjg.v21.i24.7375] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
147 Zhang J, Jiao J, Cermelli S, Muir K, Jung KH, Zou R, Rashid A, Gagea M, Zabludoff S, Kalluri R, Beretta L. miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. Cancer Res. 2015;75:1859-1867. [PMID: 25769721 DOI: 10.1158/0008-5472.can-14-1254] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
148 Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 2011;71:7608-7616. [PMID: 22009537 DOI: 10.1158/0008-5472.can-11-1144] [Cited by in Crossref: 150] [Cited by in F6Publishing: 101] [Article Influence: 13.6] [Reference Citation Analysis]
149 Sohn D, Peters D, Piekorz RP, Budach W, Jänicke RU. miR-30e controls DNA damage-induced stress responses by modulating expression of the CDK inhibitor p21WAF1/CIP1 and caspase-3. Oncotarget 2016;7:15915-29. [PMID: 26895377 DOI: 10.18632/oncotarget.7432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
150 Shaker O, Alhelf M, Morcos G, Elsharkawy A. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma. Infection, Genetics and Evolution 2017;51:173-81. [DOI: 10.1016/j.meegid.2017.03.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
151 Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J, Xing R, Jin Y, Sun Z, Zheng X. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer. 2010;46:2828-2836. [PMID: 20655737 DOI: 10.1016/j.ejca.2010.06.127] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 9.3] [Reference Citation Analysis]
152 Castro RE, Ferreira DM, Zhang X, Borralho PM, Sarver AL, Zeng Y, Steer CJ, Kren BT, Rodrigues CM. Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol. 2010;299:G887-G897. [PMID: 20689055 DOI: 10.1152/ajpgi.00216.2010] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
153 Hou YY, Cao WW, Li L, Li SP, Liu T, Wan HY, Liu M, Li X, Tang H. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 2011;307:182-190. [PMID: 21524841 DOI: 10.1016/j.canlet.2011.04.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
154 Shen J, Wang A, Wang Q, Gurvich I, Siegel AB, Remotti H, Santella RM. Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Cancer Epidemiol Biomarkers Prev. 2013;22:2364-2373. [PMID: 24127413 DOI: 10.1158/1055-9965.epi-13-0237] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
155 Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, Dai B, Zhu YP, Shen YJ, Shi GH, Ye DW. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 2011;71:326-31. [PMID: 20842666 DOI: 10.1002/pros.21246] [Cited by in Crossref: 211] [Cited by in F6Publishing: 205] [Article Influence: 17.6] [Reference Citation Analysis]
156 Bolleyn J, De Kock J, Rodrigues RM, Vinken M, Rogiers V, Vanhaecke T. MicroRNAs as key regulators of xenobiotic biotransformation and drug response. Arch Toxicol 2015;89:1523-41. [PMID: 25079447 DOI: 10.1007/s00204-014-1314-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
157 Kwiecinski M, Elfimova N, Noetel A, Töx U, Steffen HM, Hacker U, Nischt R, Dienes HP, Odenthal M. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Lab Invest. 2012;92:978-987. [PMID: 22565577 DOI: 10.1038/labinvest.2012.70] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
158 Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV. Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling. Biomed Res Int. 2015;2015:354517. [PMID: 26221589 DOI: 10.1155/2015/354517] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 11.9] [Reference Citation Analysis]
159 Ronald JA, Katzenberg R, Nielsen CH, Jae HJ, Hofmann LV, Gambhir SS. MicroRNA-regulated non-viral vectors with improved tumor specificity in an orthotopic rat model of hepatocellular carcinoma. Gene Ther 2013;20:1006-13. [PMID: 23719066 DOI: 10.1038/gt.2013.24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
160 Khella HWZ, Butz H, Ding Q, Rotondo F, Evans KR, Kupchak P, Dharsee M, Latif A, Pasic MD, Lianidou E, Bjarnason GA, Yousef GM. miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Mol Ther 2015;23:1748-58. [PMID: 26201448 DOI: 10.1038/mt.2015.129] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
161 Aravalli RN. Role of innate immunity in the development of hepatocellular carcinoma. World J Gastroenterol 2013; 19(43): 7500-7514 [PMID: 24282342 DOI: 10.3748/wjg.v19.i43.7500] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
162 Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie F, Lei L, Chen Y, Mao B, Jiang M. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29:835-842. [PMID: 24219032 DOI: 10.1111/jgh.12429] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
163 Panarelli NC, Yantiss RK. MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract. Patholog Res Int 2011;2011:124608. [PMID: 21403819 DOI: 10.4061/2011/124608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
164 Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone MG, Zaffaroni N. miR-21: an oncomir on strike in prostate cancer. Mol Cancer 2010;9:12. [PMID: 20092645 DOI: 10.1186/1476-4598-9-12] [Cited by in Crossref: 134] [Cited by in F6Publishing: 136] [Article Influence: 11.2] [Reference Citation Analysis]
165 Paul S, Kim SJ, Park H, Lee SY, An YR, Oh M, Jung JW, Ryu J, Hwang SY. Impact of miRNA deregulation on mRNA expression profiles in response to environmental toxicant, nonylphenol. Mol Cell Toxicol 2011;7:259-69. [DOI: 10.1007/s13273-011-0032-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
166 Starlard-Davenport A, Tryndyak V, Kosyk O, Ross SR, Rusyn I, Beland FA, Pogribny IP. Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis. World Rev Nutr Diet 2010;101:123-30. [PMID: 20436259 DOI: 10.1159/000314517] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
167 Jiang X, Wu J, Zhang Y, Wang S, Yu X, Li R, Huang X. MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ. Gene 2018;659:168-74. [PMID: 29551505 DOI: 10.1016/j.gene.2018.03.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
168 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
169 Valencia-Quintana R, Sánchez-Alarcón J, Tenorio-Arvide MG, Deng Y, Montiel-González JM, Gómez-Arroyo S, Villalobos-Pietrini R, Cortés-Eslava J, Flores-Márquez AR, Arenas-Huertero F. The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol 2014;5:102. [PMID: 24672518 DOI: 10.3389/fmicb.2014.00102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
170 Zeng Z, Dong J, Li Y, Dong Z, Liu Z, Huang J, Wang Y, Zhen Y, Lu Y. The expression level and diagnostic value of microRNA-22 in HCC patients. Artif Cells Nanomed Biotechnol. 2020;48:683-686. [PMID: 32088997 DOI: 10.1080/21691401.2019.1703723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Cao Y, Lv W, Ding W, Li J. Sevoflurane inhibits the proliferation and invasion of hepatocellular carcinoma cells through regulating the PTEN/Akt/GSK‑3β/β‑catenin signaling pathway by downregulating miR‑25‑3p. Int J Mol Med 2020;46:97-106. [PMID: 32319540 DOI: 10.3892/ijmm.2020.4577] [Reference Citation Analysis]
172 Wu H, Ng R, Chen X, Steer CJ, Song G. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway. Gut. 2016;65:1850-1860. [PMID: 26282675 DOI: 10.1136/gutjnl-2014-308430] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 12.9] [Reference Citation Analysis]
173 Wang Y, Jiang L, Ji X, Yang B, Zhang Y, Fu XD. Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes. J Biol Chem. 2013;288:18484-18493. [PMID: 23649629 DOI: 10.1074/jbc.m113.458158] [Cited by in Crossref: 72] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
174 Rieswijk L, Claessen SM, Bekers O, van Herwijnen M, Theunissen DH, Jennen DG, de Kok TM, Kleinjans JC, van Breda SG. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology 2016;350-352:31-9. [DOI: 10.1016/j.tox.2016.05.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
175 Zhu X, Pan H, Liu L. Long noncoding RNA network: Novel insight into hepatocellular carcinoma metastasis (Review). Int J Mol Med 2021;48:134. [PMID: 34013360 DOI: 10.3892/ijmm.2021.4967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Lupini L, Bassi C, Ferracin M, Bartonicek N, D'Abundo L, Zagatti B, Callegari E, Musa G, Moshiri F, Gramantieri L, Corrales FJ, Enright AJ, Sabbioni S, Negrini M. miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Front Genet 2013;4:64. [PMID: 23630541 DOI: 10.3389/fgene.2013.00064] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
177 Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res. 2016;2:163-186. [PMID: 28042609 DOI: 10.20517/2394-5079.2016.05] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 10.7] [Reference Citation Analysis]
178 Chen LH, Tsai KL, Chen YW, Yu CC, Chang KW, Chiou SH, Ku HH, Chu PY, Tseng LM, Huang PI, Lo WL. MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol 2010;2010:135632. [PMID: 21461395 DOI: 10.1155/2010/135632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
179 Di Martino MT, Rossi M, Caracciolo D, Gullà A, Tagliaferri P, Tassone P. Mir-221/222 are promising targets for innovative anticancer therapy. Expert Opin Ther Targets 2016;20:1099-108. [PMID: 26959615 DOI: 10.1517/14728222.2016.1164693] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
180 Hou X, Liang Y, Chen J, Wei Y, Zeng P, Wang L, Lu C, Diao H. Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients. Biomed Res Int 2017;2017:6484835. [PMID: 28913356 DOI: 10.1155/2017/6484835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
181 Piluso A, Gragnani L, Fognani E, Grandini E, Monti M, Stasi C, Loggi E, Margotti M, Conti F, Andreone P, Zignego AL. Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies. Hepatol Int 2015;9:586-93. [PMID: 26272105 DOI: 10.1007/s12072-015-9658-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
182 Zhang L, Yu Z, Xian Y, Lin X. microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma. FEBS Open Bio 2016;6:155-64. [PMID: 27239437 DOI: 10.1002/2211-5463.12032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]